Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 1, 1999, Pages 5-12

  Haustein, Knut Olaf ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Drug interactions; Pharmacokinetics; Phenprocoumon; Phytomenadion; Prothrombin time

Indexed keywords

ACENOCOUMAROL; BLOOD CLOTTING FACTOR; COUMARIN ANTICOAGULANT; PHENPROCOUMON; PHYTOMENADIONE; WARFARIN;

ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; BLEEDING; DISTRIBUTION VOLUME; DOSE RESPONSE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INDICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG MONITORING; DRUG PROTEIN BINDING; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTHROMBIN TIME; STEADY STATE;

EID: 0032960647     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-996417     Document Type: Article

References (20)

1. 1. Deutsch E. Klinische Anwendung der Antikoagulantien. In: Markwardt F, ed. Anticoagulantien, Handbuch Exptl Pharmacology, Vol. 27. Berlin-Heidelberg-New York: Springer-Verlag; 1971:302-508
2. 2. Haustein KO, Markwardt F. 4-Hydroxy-cumarine, Bis-hydroycumarine und 1,3-Indandione. In: Markwardt F, ed. Anticoagulantien, Handbuch Exptl Pharmacology, Vol. 27. Berlin-Heidelberg-New York: Springer-Verlag; 1971:192-301
3. 3. Owren PA, Aas K. The control of dicoumarol therapy and the quantitative determination of prothrombin and proconvertin. Scand J Clin Lab Invest 1951;3:201-211
4. 4. Quick AJ. The development and use of the prothrombin test. Circulation 1959;19:92-98
5. 5. Markwardt F. Die quantitative Bestimmung des Prothrombins durch Titration mit Hirudin. Naunyn-Schmiedeberg's Arch Exp Pathol Pharmakol 1958;232:487-498
6. 6. Markwardt F, Wenzel G. Die Anwendung der Prothrombinbestimmung mit Hirudin zur Überwachung der Behandlung mit Dicumarolderivaten. Blut 1961;7:37-42
7. 7. Morris DP, Soute BAM, Vermeer C, Stafford DW. Characterization of the purified K-dependent γ-glutamyl carboxylase. J Biol Chem 1993;268:8735-8742
8. 8. Thijssen HH, Drittij-Reijnders MJ. Vitamin K metabolism and vitamin K1 status in human liver samples: A search for inter-individual differences in warfarin sensitivity. Br J Haematol 1993;84:681-685
9. 9. O'Reilly RA. Vitamin K and oral anticoagulant drugs as competitive antagonists in man. Pharmacology (Base) 1972;7:149-158
10. 10. Bell RG, Matschiner JT. Warfarin and the inhibition of vitamin K activity by an oxide metabolite. Nature (Lond) 1972;237: 32-33
11. 11. Thijssen HH, Hamulyak K, Willigers H. 4-Hydroxycoumarin oral anticoagulants: Pharmacokinetics-response relationship. Thromb Haemostas 1988;60:35-38
12. 12. Haustein KO, Richter M, Vogel G. Zur Optimierung einer Langzeitbehandlung mit Phenprocoumon. Dtsch Gesundheitswesen 1975;30:1514-1518
13. 13. Haustein KO, Huller G. Pharmacokinetics of phenprocoumon. Int J Clin Pharmacol Ther 1994;32:192-197
14. 14. Haustein KO. Interaction between phenprocoumon and phytomenadion: A pharmacokinetic investigation in healthy volunteers. Biomed Biochim Acta 1984;43:1417-1424
15. 15. Haustein KO, Richter M, Vogel G, Mittag E. Individualization of drug dosage during long-term treatment with phenprocoumon (Falithrom®). Int J Clin Pharmacol 1978;16:372-376
16. 16. Sise HS, Lavelle SM, Dionysios A, Becker R. Relations of hemorrhage and thrombosis to prothrombin during treatment with coumarin-typ anticoagulants. N Engl J Med 1958;259: 266-271
17. 17. Quick AJ. Leafy vegetables in diet alter prothrombin time in patients taking anticoagulant drugs. JAMA 1964;137:27-32
18. 18. Frick PG, Riedler G, Brögli H. Dose response and minimal daily requirement for vitamin K in man. J Appl Physiol 1967;23: 387-389
19. 19. Lind SE, Callas PW, Golden EA, Joyner KA Jr, Ortel TL. Plasma levels of factors II, VII and X and their relationship to the international normalized ratio during chronic warfarin therapy. Blood Coag Fibrinolysis 1997;8:48-53
20. 20. Haefelfinger P. A specific and sensitive method for the determination of the anticoagulant phenprocoumon in plasma. J Chromatogr 1979;162:215-222